ATE207902T1 - Cyclische amidderivate als schutzmittel gegen ultraviolettstrahlung - Google Patents
Cyclische amidderivate als schutzmittel gegen ultraviolettstrahlungInfo
- Publication number
- ATE207902T1 ATE207902T1 AT95925113T AT95925113T ATE207902T1 AT E207902 T1 ATE207902 T1 AT E207902T1 AT 95925113 T AT95925113 T AT 95925113T AT 95925113 T AT95925113 T AT 95925113T AT E207902 T1 ATE207902 T1 AT E207902T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- pct
- activity
- amide derivatives
- cyclic amide
- Prior art date
Links
- 150000003950 cyclic amides Chemical class 0.000 title abstract 2
- 239000011814 protection agent Substances 0.000 title 1
- 230000005855 radiation Effects 0.000 title 1
- 230000000694 effects Effects 0.000 abstract 3
- 125000003302 alkenyloxy group Chemical group 0.000 abstract 2
- -1 lipid peroxides Chemical class 0.000 abstract 2
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004465 cycloalkenyloxy group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000005554 pyridyloxy group Chemical group 0.000 abstract 1
- 230000002000 scavenging effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/60—Quinoline or hydrogenated quinoline ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Surface Treatment Of Glass Fibres Or Filaments (AREA)
- Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16163994 | 1994-07-14 | ||
| PCT/JP1995/001392 WO1996002508A1 (en) | 1994-07-14 | 1995-07-12 | Cyclic amide derivatives for protecting against ultraviolet rays |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE207902T1 true ATE207902T1 (de) | 2001-11-15 |
Family
ID=15739015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95925113T ATE207902T1 (de) | 1994-07-14 | 1995-07-12 | Cyclische amidderivate als schutzmittel gegen ultraviolettstrahlung |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5786367A (de) |
| EP (1) | EP0719258B1 (de) |
| KR (1) | KR100396232B1 (de) |
| CN (1) | CN1084330C (de) |
| AT (1) | ATE207902T1 (de) |
| AU (1) | AU689281B2 (de) |
| CA (1) | CA2170520A1 (de) |
| DE (1) | DE69523548T2 (de) |
| DK (1) | DK0719258T3 (de) |
| ES (1) | ES2167443T3 (de) |
| MX (1) | MX9600842A (de) |
| PT (1) | PT719258E (de) |
| TW (1) | TW448161B (de) |
| WO (1) | WO1996002508A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW436483B (en) * | 1997-08-19 | 2001-05-28 | Otsuka Pharma Co Ltd | Carbostyril derivatives, process for their preparation and pharmaceutical composition or cosmetic composition for inhibiting skin erythema and/or skin pigmentation |
| EP1057491B1 (de) * | 1998-02-24 | 2013-06-19 | Astellas Pharma Inc. | Vorbeuge- und Heilmittel gegen die Hautalterung |
| US6906063B2 (en) | 2000-02-04 | 2005-06-14 | Portola Pharmaceuticals, Inc. | Platelet ADP receptor inhibitors |
| US6403075B1 (en) * | 2000-03-15 | 2002-06-11 | Dragoco Gerberding & Co. Ag | Odor suppression in ammonia-containing cosmetic products |
| US20040192669A1 (en) | 2000-04-13 | 2004-09-30 | Rosenfeld Mark J. | Novel compounds for use in weight loss and appetite suppression in humans |
| US7794761B2 (en) * | 2000-04-13 | 2010-09-14 | Seroctin Research & Technology, Inc. | Methods for inducing anti-anxiety and calming effects in animals and humans |
| DE10063946A1 (de) * | 2000-12-20 | 2002-07-04 | Basf Ag | Verwendung von Lichtschutzmittelkombinationen, die als wesentlichen Bestandteil 2,2'-p-Phenylen-bis(3,1-benzoxazin-4-on) enthalten als photostabile UV-Filter in kosmetischen und pharmazeutischen Zubereitungen |
| JP2004529110A (ja) | 2001-03-06 | 2004-09-24 | アストラゼネカ アクチボラグ | 脈管損傷活性を有するインドール誘導体 |
| TWI250023B (en) * | 2001-10-22 | 2006-03-01 | Santen Pharmaceutical Co Ltd | Pharmaceutical composition for itch treating agent |
| WO2003057672A2 (en) * | 2001-12-28 | 2003-07-17 | Acadia Pharmaceuticals, Inc. | Tetrahydroquinoline analogues as muscarinic agonists |
| US7550459B2 (en) | 2001-12-28 | 2009-06-23 | Acadia Pharmaceuticals, Inc. | Tetrahydroquinoline analogues as muscarinic agonists |
| US7524877B2 (en) | 2003-11-20 | 2009-04-28 | Seroctin Research & Technology, Inc. | Compounds for use in weight loss and appetite suppression in humans |
| WO2005077884A2 (en) | 2004-02-10 | 2005-08-25 | Union Carbide Chemicals & Plastics Technology Corporation | Hydroaminomethylation of olefins |
| DK1951254T3 (da) | 2005-11-03 | 2012-05-07 | Portola Pharm Inc | (4-(6-halo-7-substitueret-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl)¨-5-chlorthiophen-2-yl-sulfonylureaer og former og fremgangsmåder der er relateret dertil |
| EP2247949B1 (de) * | 2008-01-25 | 2017-05-24 | Bayer Consumer Care AG | Verfahren zur auswahl von antioxidantien zur verwendung in topisch angewandten zusammensetzungen |
| US20090197878A1 (en) * | 2008-02-01 | 2009-08-06 | Wyeth | SUBSTITUTED BENZO[d][1,3]OXAZIN-2(4H)-ONES AND RELATED DERIVATIVES AND THEIR USES FOR MODULATING THE PROGESTERONE RECEPTOR |
| GR1007084B (el) * | 2008-08-07 | 2010-11-26 | Ευτυχια Κοϊνη | 1,4- βενζοξαζινικα αναλογα |
| TW201039822A (en) * | 2009-02-06 | 2010-11-16 | Taisho Pharmaceutical Co Ltd | Dihydroquinolinone derivatives |
| GB2532990A (en) | 2014-12-05 | 2016-06-08 | Schlumberger Holdings | Corrosion inhibition |
| GB2543498A (en) | 2015-10-19 | 2017-04-26 | Schlumberger Holdings | Corrosion inhibition |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1294285C (en) * | 1983-03-13 | 1992-01-14 | Robert T. Buckler | Optical indicator chalcogen compounds and methods for their preparation and use |
| US4558130A (en) * | 1984-03-27 | 1985-12-10 | Miles Laboratories, Inc. | Fluorogenic dihydroquinolone and dihydrocoumarin indicators for hydrogen peroxide |
| JPS63168403A (ja) * | 1987-01-06 | 1988-07-12 | Fuji Photo Film Co Ltd | 光重合性組成物 |
| JPH07121937B2 (ja) * | 1987-03-18 | 1995-12-25 | 大塚製薬株式会社 | カルボスチリル誘導体 |
| JPH0699497B2 (ja) * | 1987-04-16 | 1994-12-07 | 富士写真フイルム株式会社 | 光重合性組成物 |
| JPS63290821A (ja) * | 1987-05-25 | 1988-11-28 | Otsuka Pharmaceut Co Ltd | 抗不整脈剤 |
| US5081044A (en) * | 1990-09-28 | 1992-01-14 | Miles Inc. | Detection of hydrogen peroxide with optical indicator chalcogen compounds |
| MX9200299A (es) * | 1991-02-07 | 1992-12-01 | Roussel Uclaf | Nuevos derivados biciclicos nitrogenados, su procedimiento de preparacion los nuevos compuestos intermedios obtenidos su aplicacion como medicamentos y las composiciones farmaceuticas que los contienen. |
| JP3406600B2 (ja) * | 1992-05-01 | 2003-05-12 | 興和株式会社 | キノリン誘導体又はその塩，及びこれを含有する心疾患治療剤 |
-
1995
- 1995-07-10 TW TW084107134A patent/TW448161B/zh active
- 1995-07-12 PT PT95925113T patent/PT719258E/pt unknown
- 1995-07-12 US US08/600,987 patent/US5786367A/en not_active Expired - Fee Related
- 1995-07-12 EP EP95925113A patent/EP0719258B1/de not_active Expired - Lifetime
- 1995-07-12 KR KR1019960701301A patent/KR100396232B1/ko not_active Expired - Fee Related
- 1995-07-12 WO PCT/JP1995/001392 patent/WO1996002508A1/en not_active Ceased
- 1995-07-12 CA CA002170520A patent/CA2170520A1/en not_active Abandoned
- 1995-07-12 AU AU29361/95A patent/AU689281B2/en not_active Ceased
- 1995-07-12 MX MX9600842A patent/MX9600842A/es not_active IP Right Cessation
- 1995-07-12 DK DK95925113T patent/DK0719258T3/da active
- 1995-07-12 ES ES95925113T patent/ES2167443T3/es not_active Expired - Lifetime
- 1995-07-12 DE DE69523548T patent/DE69523548T2/de not_active Expired - Fee Related
- 1995-07-12 CN CN95190634A patent/CN1084330C/zh not_active Expired - Fee Related
- 1995-07-12 AT AT95925113T patent/ATE207902T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2167443T3 (es) | 2002-05-16 |
| US5786367A (en) | 1998-07-28 |
| PT719258E (pt) | 2002-03-28 |
| DE69523548T2 (de) | 2002-05-02 |
| CN1130377A (zh) | 1996-09-04 |
| KR960704849A (ko) | 1996-10-09 |
| KR100396232B1 (ko) | 2004-02-05 |
| DE69523548D1 (de) | 2001-12-06 |
| CN1084330C (zh) | 2002-05-08 |
| MX9600842A (es) | 1997-06-28 |
| TW448161B (en) | 2001-08-01 |
| AU689281B2 (en) | 1998-03-26 |
| AU2936195A (en) | 1996-02-16 |
| DK0719258T3 (da) | 2001-11-26 |
| EP0719258B1 (de) | 2001-10-31 |
| WO1996002508A1 (en) | 1996-02-01 |
| CA2170520A1 (en) | 1996-02-01 |
| EP0719258A1 (de) | 1996-07-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE207902T1 (de) | Cyclische amidderivate als schutzmittel gegen ultraviolettstrahlung | |
| ATE188472T1 (de) | 4-arylmethyloxymethyl piperidine als tachykinin antagonisten | |
| DE60019904D1 (de) | Verwendung von sulfamat derivaten zur behandlung von impulsiven störungen | |
| FR2695560B1 (fr) | Composition cosmétique filtrante photostable contenant un filtre UV-A et un polymère filtre du type silicone benzotriazole. | |
| DE69523169D1 (de) | Verwendung von Mangiferin oder seinen Derivaten zur kosmetischen Anwendung | |
| ATE205187T1 (de) | Metalloproteinase hemmende verbindungen | |
| SE9600164L (sv) | Stabilisatorkombination | |
| MX9701685A (es) | Nuevos derivados de bencimidazol que tienen la actividad de inhibicion de la fosfodiestearasa cgmp. | |
| LU92263I2 (fr) | Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION) | |
| DE69833797D1 (de) | Substituierte 2-benzylamino-2-phenyl-acetamidverbindungen | |
| ES2191341T3 (es) | Derivados de la 2-fenoxianilina. | |
| ES2181927T3 (es) | Derivados de 1-metilcarbapenem. | |
| ATE245447T1 (de) | Inhibitor von gehirnödemen | |
| DE69513679D1 (de) | 6-polyfluoralkoxy und 6-polyfluoralkyl-2-amino benzothiazole-derivate | |
| ATE153657T1 (de) | Cyclische benzylamino-, benzylamido- und benzylimido derivate als antipsychotische wirkstoffe | |
| DK0720598T3 (da) | Phenoxyphenylcyclopentenyl-hydroxyurinstoffer | |
| MX9801892A (es) | Nitrones ciclicos y composiciones farmaceuticas que los contienen. | |
| ATE159511T1 (de) | Derivate von n,n,n',n'-tetrasubstituierten 1,2- ethylendiamin-verbindungen | |
| NZ236186A (en) | Pyrrolidine and piperidine derivatives and pharmaceutical compositions | |
| ATE181734T1 (de) | N-benzoylmethylsubstituierte paroxetinderivate | |
| ATE158301T1 (de) | 4-aza-pregnan-5-alpha-reductase isozym 1 inhibitoren | |
| ES2087567T3 (es) | Derivados antibioticos de 7'-amino-naftazarina. | |
| ATE238286T1 (de) | Neue triazole als therapeutische mittel gegen pilzinfektionen | |
| SE9603284D0 (sv) | New compounds | |
| NO963208L (no) | Anvendelse av 1,3,2-benzoditiazol-1-oksyder som mikrobiocider for beskyttelse av tekniske materialer såvel som visse 1,3,2-benzoditiazol-1-oksyder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |